High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Keywords

BiomarkerAmyloid (mycology)Pittsburgh compound BPositron emission tomographyDiseaseMedicineAlzheimer's diseaseCerebrospinal fluidAlzheimer's Disease Neuroimaging InitiativeNeuroimagingOncologyPathologyAmyloid precursor proteinInternal medicineNuclear medicineChemistryBiochemistryPsychiatry

Affiliated Institutions

Related Publications

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans

Anne M. Fagan , Mark A. Mintun , Robert H. Mach +10 more

Abstract Objectives Amyloid‐β 42 (Aβ 42 ) appears central to Alzheimer's disease (AD) pathogenesis and is a major component of amyloid plaques. Mean cerebrospinal fluid (CSF) Aβ...

2005 Annals of Neurology 1238 citations

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Leslie M. Shaw , Hugo Vanderstichele , Małgorzata Knapik-Czajka +12 more

Abstract Objective Develop a cerebrospinal fluid biomarker signature for mild Alzheimer's disease (AD) in Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects. Methods Am...

2009 Annals of Neurology 2041 citations

Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia

William J. Jagust

Abstract Background The diagnosis of dementia, along with the prediction of who will develop dementia, has been assisted by the development of the brain imaging techniques of ma...

2006 Alzheimer s & Dementia 72 citations

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Marilyn S. Albert , Steven T. DeKosky , Dennis W. Dickson +11 more

The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's dis...

2011 Alzheimer s & Dementia 9670 citations

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Clifford R. Jack , Val J. Lowe , Matthew L. Senjem +8 more

To date, most diagnostic imaging comparisons between amyloid labelling ligands and other imaging modalities have been between the use of amyloid labelling ligand (11)C Pittsburg...

2008 Brain 944 citations

Publication Info

Year: 2018
Type: article
Volume: 554
Issue: 7691
Pages: 249-254
Citations: 1587
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1587

OpenAlex

Cite This

APA Style

                            
                                
                                    Akinori Nakamura, 
                                
                                    Naoki Kaneko, 
                                
                                    Victor L. Villemagne
                                
                                et al.
                            
                            (2018). 
                            High performance plasma amyloid-β biomarkers for Alzheimer’s disease. 
                            Nature
                            , 554
                            (7691)
                            , 249-254.
                            https://doi.org/10.1038/nature25456
                        

Identifiers

DOI: 10.1038/nature25456